{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:33:53Z","timestamp":1792701233269,"version":"4.5.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002543","name":"Pusan National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12272-021-01352-4","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T02:51:21Z","timestamp":1634611881000},"page":"839-856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Targeting fatty acid metabolism for fibrotic disorders"],"prefix":"10.1007","volume":"44","author":[{"given":"Seonghwan","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Wung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"1352_CR1","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1126\/science.1056843","volume":"291","author":"L Abu-Elheiga","year":"2001","unstructured":"Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613\u20132616. https:\/\/doi.org\/10.1126\/science.1056843","journal-title":"Science"},{"key":"1352_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbalip.2012.09.010","volume":"1831","author":"M Agassandian","year":"2013","unstructured":"Agassandian M, Mallampalli RK (2013) Surfactant phospholipid metabolism. Biochim Biophys Acta 1831:612\u2013625. https:\/\/doi.org\/10.1016\/j.bbalip.2012.09.010","journal-title":"Biochim Biophys Acta"},{"key":"1352_CR3","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s10620-014-3289-x","volume":"59","author":"SB Ahn","year":"2014","unstructured":"Ahn SB, Jang K, Jun DW, Lee BH, Shin KJ (2014) Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 59:2975\u20132982. https:\/\/doi.org\/10.1007\/s10620-014-3289-x","journal-title":"Dig Dis Sci"},{"key":"1352_CR4","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1136\/annrheumdis-2016-210821","volume":"76","author":"J Avouac","year":"2017","unstructured":"Avouac J, Konstantinova I, Guignabert C, Pezet S, Sadoine J, Guilbert T, Cauvet A, Tu L, Luccarini JM, Junien JL, Broqua P, Allanore Y (2017) Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension. Ann Rheum Dis 76:1931\u20131940. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210821","journal-title":"Ann Rheum Dis"},{"key":"1352_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","volume":"73","author":"J Bates","year":"2020","unstructured":"Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D, Zagorska A, Hollenback D, Walker K, Liu K, Pendem S, Newstrom D, Brockett R, Mikaelian I, Kusam S, Ramirez R, Lopez D, Li L, Fuchs BC, Breckenridge DG (2020) Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol 73:896\u2013905. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.037","journal-title":"J Hepatol"},{"key":"1352_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1053\/j.gastro.2010.11.053","volume":"140","author":"SW Beaven","year":"2011","unstructured":"Beaven SW, Wroblewski K, Wang J, Hong C, Bensinger S, Tsukamoto H, Tontonoz P (2011) Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology 140:1052\u20131062. https:\/\/doi.org\/10.1053\/j.gastro.2010.11.053","journal-title":"Gastroenterology"},{"key":"1352_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cmet.2013.04.021","volume":"18","author":"SW Beaven","year":"2013","unstructured":"Beaven SW, Matveyenko A, Wroblewski K, Chao L, Wilpitz D, Hsu TW, Lentz J, Drew B, Hevener AL, Tontonoz P (2013) Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance. Cell Metab 18:106\u2013117. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.021","journal-title":"Cell Metab"},{"key":"1352_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56:952\u2013964. https:\/\/doi.org\/10.1016\/j.jhep.2011.08.025","journal-title":"J Hepatol"},{"key":"1352_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cells7090137","author":"M Bobowski-Gerard","year":"2018","unstructured":"Bobowski-Gerard M, Zummo FP, Staels B, Lefebvre P, Eeckhoute J (2018) Retinoids issued from hepatic stellate cell lipid droplet loss as potential signaling molecules orchestrating a multicellular liver injury response. Cells. https:\/\/doi.org\/10.3390\/cells7090137","journal-title":"Cells"},{"key":"1352_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","volume":"19","author":"IA Bobulescu","year":"2010","unstructured":"Bobulescu IA (2010) Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 19:393\u2013402. https:\/\/doi.org\/10.1097\/MNH.0b013e32833aa4ac","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1352_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fimmu.2015.00602","volume":"6","author":"TT Braga","year":"2015","unstructured":"Braga TT, Agudelo JS, Camara NO (2015) Macrophages during the fibrotic process: M2 as friend and foe. Front Immunol 6:602. https:\/\/doi.org\/10.3389\/fimmu.2015.00602","journal-title":"Front Immunol"},{"key":"1352_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cgh.2017.12.001","volume":"16","author":"F Bril","year":"2018","unstructured":"Bril F, Kalavalapalli S, Clark VC, Lomonaco R, Soldevila-Pico C, Liu IC, Orsak B, Tio F, Cusi K (2018) Response to pioglitazone in patients with nonalcoholic steatohepatitis with vs without type 2 diabetes. Clin Gastroenterol Hepatol 16:558-566.e2. https:\/\/doi.org\/10.1016\/j.cgh.2017.12.001","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1352_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000488816","volume":"46","author":"MC Bulbul","year":"2018","unstructured":"Bulbul MC, Dagel T, Afsar B, Ulusu NN, Kuwabara M, Covic A, Kanbay M (2018) Disorders of lipid metabolism in chronic kidney disease. Blood Purif 46:144\u2013152. https:\/\/doi.org\/10.1159\/000488816","journal-title":"Blood Purif"},{"key":"1352_CR14","doi-asserted-by":"publisher","first-page":"L1146","DOI":"10.1152\/ajplung.00383.2004","volume":"288","author":"HA Burgess","year":"2005","unstructured":"Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ (2005) PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 288:L1146\u2013L1153. https:\/\/doi.org\/10.1152\/ajplung.00383.2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1352_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111423","author":"ML Chang","year":"2019","unstructured":"Chang ML, Yang SS (2019) Metabolic signature of hepatic fibrosis: from individual pathways to systems biology. Cells. https:\/\/doi.org\/10.3390\/cells8111423","journal-title":"Cells"},{"key":"1352_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jmcb\/mju041","volume":"6","author":"G Chen","year":"2014","unstructured":"Chen G, Wang T, Uttarwar L, Vankrieken R, Li R, Chen X, Gao B, Ghayur A, Margetts P, Krepinsky JC (2014) SREBP-1 is a novel mediator of TGFbeta1 signaling in mesangial cells. J Mol Cell Biol 6:516\u2013530. https:\/\/doi.org\/10.1093\/jmcb\/mju041","journal-title":"J Mol Cell Biol"},{"key":"1352_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41419-020-03199-x","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yan Q, Lv M, Song K, Dai Y, Huang Y, Zhang L, Zhang C, Gao H (2020) Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis. Cell Death Dis 11:994. https:\/\/doi.org\/10.1038\/s41419-020-03199-x","journal-title":"Cell Death Dis"},{"key":"1352_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/nm1116","volume":"10","author":"L Cheng","year":"2004","unstructured":"Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245\u20131250. https:\/\/doi.org\/10.1038\/nm1116","journal-title":"Nat Med"},{"key":"1352_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1172\/JCI10947","volume":"107","author":"HC Chiu","year":"2001","unstructured":"Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE (2001) A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107:813\u2013822. https:\/\/doi.org\/10.1172\/JCI10947","journal-title":"J Clin Invest"},{"key":"1352_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","volume":"96","author":"HC Chiu","year":"2005","unstructured":"Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE (2005) Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 96:225\u2013233. https:\/\/doi.org\/10.1161\/01.RES.0000154079.20681.B9","journal-title":"Circ Res"},{"key":"1352_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1165\/rcmb.2018-0324OC","volume":"61","author":"SG Chu","year":"2019","unstructured":"Chu SG, Villalba JA, Liang X, Xiong K, Tsoyi K, Ith \nB, Ayaub EA, Tatituri RV, Byers DE, Hsu FF, El-Chemaly S, Kim EY, Shi Y, Rosas IO (2019) Palmitic acid-rich high-fat diet exacerbates experimental pulmonary fibrosis by modulating endoplasmic reticulum stress. Am J Respir Cell Mol Biol 61:737\u2013746. https:\/\/doi.org\/10.1165\/rcmb.2018-0324OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1352_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2017070802","volume":"29","author":"KW Chung","year":"2018","unstructured":"Chung KW, Lee EK, Lee MK, Oh GT, Yu BP, Chung HY (2018) Impairment of PPARalpha and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J Am Soc Nephrol 29:1223\u20131237. https:\/\/doi.org\/10.1681\/ASN.2017070802","journal-title":"J Am Soc Nephrol"},{"key":"1352_CR23","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1038\/s41467-019-11327-1","volume":"10","author":"KP Chung","year":"2019","unstructured":"Chung KP, Hsu CL, Fan LC, Huang Z, Bhatia D, Chen YJ, Hisata S, Cho SJ, Nakahira K, Imamura M, Choi ME, Yu CJ, Cloonan SM, Choi AMK (2019) Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis. Nat Commun 10:3390. https:\/\/doi.org\/10.1038\/s41467-019-11327-1","journal-title":"Nat Commun"},{"key":"1352_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/gerona\/glz083","volume":"75","author":"KW Chung","year":"2020","unstructured":"Chung KW, Ha S, Kim SM, Kim DH, An HJ, Lee EK, Moon HR, Chung HY (2020) PPARalpha\/beta activation alleviates age-associated renal fibrosis in sprague dawley rats. J Gerontol A Biol Sci Med Sci 75:452\u2013458. https:\/\/doi.org\/10.1093\/gerona\/glz083","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1352_CR25","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1172\/JCI114943","volume":"86","author":"BH Davis","year":"1990","unstructured":"Davis BH, Kramer RT, Davidson NO (1990) Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest 86:2062\u20132070. https:\/\/doi.org\/10.1172\/JCI114943","journal-title":"J Clin Invest"},{"key":"1352_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","volume":"10","author":"JA Del Campo","year":"2018","unstructured":"Del Campo JA, Gallego P, Grande L (2018) Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol 10:1\u20137. https:\/\/doi.org\/10.4254\/wjh.v10.i1.1","journal-title":"World J Hepatol"},{"key":"1352_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.11.011","volume":"33","author":"P Dhillon","year":"2021","unstructured":"Dhillon P, Park J, Hurtado Del Pozo C, Li L, Doke T, Huang S, Zhao J, Kang HM, Shrestra R, Balzer MS, Chatterjee S, Prado P, Han SY, Liu H, Sheng X, Dierickx P, Batmanov K, Romero JP, Prosper F, Li M, Pei L, Kim J, Montserrat N, Susztak K (2021) The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation. Cell Metab 33:379-394.e8. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.011","journal-title":"Cell Metab"},{"key":"1352_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler JHW, Gyorfi AH, Ramanujam M, Whitfield ML, Konigshoff M, Lafyatis R (2019) Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol 15:705\u2013730. https:\/\/doi.org\/10.1038\/s41584-019-0322-7","journal-title":"Nat Rev Rheumatol"},{"key":"1352_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","volume":"65","author":"S Djudjaj","year":"2019","unstructured":"Djudjaj S, Boor P (2019) Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 65:16\u201336. https:\/\/doi.org\/10.1016\/j.mam.2018.06.002","journal-title":"Mol Aspects Med"},{"key":"1352_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fphar.2020.00265","volume":"11","author":"D Dorotea","year":"2020","unstructured":"Dorotea D, Koya D, Ha H (2020) Recent insights into SREBP as a direct mediator of kidney fibrosis via lipid-independent pathways. Front Pharmacol 11:265. https:\/\/doi.org\/10.3389\/fphar.2020.00265","journal-title":"Front Pharmacol"},{"key":"1352_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.109.888735","volume":"121","author":"JG Duncan","year":"2010","unstructured":"Duncan JG, Bharadwaj KG, Fong JL, Mitra R, Sambandam N, Courtois MR, Lavine KJ, Goldberg IJ, Kelly DP (2010) Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation 121:426\u2013435. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.888735","journal-title":"Circulation"},{"key":"1352_CR32","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","volume":"190","author":"RM Dunham","year":"2013","unstructured":"Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, Grakoui A (2013) Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol 190:2009\u20132016. https:\/\/doi.org\/10.4049\/jimmunol.1201937","journal-title":"J Immunol"},{"key":"1352_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","volume":"34","author":"F Faghihzadeh","year":"2014","unstructured":"Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A (2014) Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res 34:837\u2013843. https:\/\/doi.org\/10.1016\/j.nutres.2014.09.005","journal-title":"Nutr Res"},{"key":"1352_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1172\/JCI14080","volume":"109","author":"BN Finck","year":"2002","unstructured":"Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP (2002) The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109:121\u2013130. https:\/\/doi.org\/10.1172\/JCI14080","journal-title":"J Clin Invest"},{"key":"1352_CR35","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1073\/pnas.0336724100","volume":"100","author":"BN Finck","year":"2003","unstructured":"Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP (2003) A \ncritical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100:1226\u20131231. https:\/\/doi.org\/10.1073\/pnas.0336724100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1352_CR36","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","volume":"32","author":"Y Fu","year":"2020","unstructured":"Fu Y, Sun Y, Wang M, Hou Y, Huang W, Zhou D, Wang Z, Yang S, Tang W, Zhen J, Li Y, Wang X, Liu M, Zhang Y, Wang B, Liu G, Yu X, Sun J, Zhang C, Yi F (2020) Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism. Cell Metab 32:1052-1062.e8. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.019","journal-title":"Cell Metab"},{"key":"1352_CR37","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/gast.2002.33666","volume":"122","author":"A Galli","year":"2002","unstructured":"Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, Casini A (2002) Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 122:1924\u20131940. https:\/\/doi.org\/10.1053\/gast.2002.33666","journal-title":"Gastroenterology"},{"key":"1352_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/01.shk.0000190825.28783.a4","volume":"24","author":"T Genovese","year":"2005","unstructured":"Genovese T, Mazzon E, Di Paola R, Muia C, Crisafulli C, Caputi AP, Cuzzocrea S (2005) Role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha in the development of bleomycin-induced lung injury. Shock 24:547\u2013555. https:\/\/doi.org\/10.1097\/01.shk.0000190825.28783.a4","journal-title":"Shock"},{"key":"1352_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","volume":"127","author":"AA Gibb","year":"2020","unstructured":"Gibb AA, Lazaropoulos MP, Elrod JW (2020) Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ Res 127:427\u2013447. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316958","journal-title":"Circ Res"},{"key":"1352_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck","year":"2018","unstructured":"Gieseck RL, Wilson MS, Wynn TA (2018) Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol 18:62\u201376. https:\/\/doi.org\/10.1038\/nri.2017.90","journal-title":"Nat Rev Immunol"},{"key":"1352_CR41","doi-asserted-by":"publisher","first-page":"158674","DOI":"10.1016\/j.bbalip.2020.158674","volume":"1865","author":"MW Haaker","year":"2020","unstructured":"Haaker MW, Vaandrager AB, Helms JB (2020) Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158674. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158674","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1352_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15693","author":"RB Hamanaka","year":"2021","unstructured":"Hamanaka RB, Mutlu GM (2021) Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism. FEBS J. https:\/\/doi.org\/10.1111\/febs.15693","journal-title":"FEBS J"},{"key":"1352_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1513\/AnnalsATS.201411-507FR","volume":"12","author":"S Han","year":"2015","unstructured":"Han S, Mallampalli RK (2015) The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc 12:765\u2013774. https:\/\/doi.org\/10.1513\/AnnalsATS.201411-507FR","journal-title":"Ann Am Thorac Soc"},{"key":"1352_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1681\/ASN.2014121181","volume":"27","author":"SH Han","year":"2016","unstructured":"Han SH, Malaga-Dieguez L, Chinga F, Kang HM, Tao J, Reidy K, Susztak K (2016) Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J Am Soc Nephrol 27:439\u2013453. https:\/\/doi.org\/10.1681\/ASN.2014121181","journal-title":"J Am Soc Nephrol"},{"key":"1352_CR45","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1681\/ASN.2017020130","volume":"28","author":"SH Han","year":"2017","unstructured":"Han SH, Wu MY, Nam BY, Park JT, Yoo TH, Kang SW, Park J, Chinga F, Li SY, Susztak K (2017) PGC-1alpha protects from notch-induced kidney fibrosis development. J Am Soc Nephrol 28:3312\u20133322. https:\/\/doi.org\/10.1681\/ASN.2017020130","journal-title":"J Am Soc Nephrol"},{"key":"1352_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama T, Riezman H (2018) Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol 19:281\u2013296. https:\/\/doi.org\/10.1038\/nrm.2017.138","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1352_CR47","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tem.2021.05.003","volume":"32","author":"J Henderson","year":"2021","unstructured":"Henderson J, O\u2019reilly S (2021) The emerging role of metabolism in fibrosis. Trends Endocrinol Metab 32:639\u2013653. https:\/\/doi.org\/10.1016\/j.tem.2021.05.003","journal-title":"Trends Endocrinol Metab"},{"key":"1352_CR48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587:555\u2013566. https:\/\/doi.org\/10.1038\/s41586-020-2938-9","journal-title":"Nature"},{"key":"1352_CR49","doi-asserted-by":"publisher","first-page":"645857","DOI":"10.3389\/fphys.2021.645857","volume":"12","author":"TD Hewitson","year":"2021","unstructured":"Hewitson TD, Smith ER (2021) A metabolic reprogramming of glycolysis and glutamine metabolism is a requisite for renal fibrogenesis-why and how? Front Physiol 12:645857. https:\/\/doi.org\/10.3389\/fphys.2021.645857","journal-title":"Front Physiol"},{"key":"1352_CR50","doi-asserted-by":"publisher","first-page":"42477","DOI":"10.1038\/srep42477","volume":"7","author":"Y Honda","year":"2017","unstructured":"Honda Y, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Takizawa T, Saito S, Nagashima Y, Nakajima A (2017) Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. Sci Rep 7:42477. https:\/\/doi.org\/10.1038\/srep42477","journal-title":"Sci Rep"},{"key":"1352_CR51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","volume":"33","author":"SM Houten","year":"2010","unstructured":"Houten SM, Wanders RJ (2010) A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis 33:469\u2013477. https:\/\/doi.org\/10.1007\/s10545-010-9061-2","journal-title":"J Inherit Metab Dis"},{"key":"1352_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJ (2016) The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu Rev Physiol 78:23\u201344. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105045","journal-title":"Annu Rev Physiol"},{"key":"1352_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1743-7075-7-47","volume":"7","author":"J Hu","year":"2010","unstructured":"Hu J, Zhang Z, Shen WJ, Azhar S (2010) Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond) 7:47. https:\/\/doi.org\/10.1186\/1743-7075-7-47","journal-title":"Nutr Metab (Lond)"},{"key":"1352_CR54","doi-asserted-by":"publisher","first-page":"8071093","DOI":"10.1155\/2018\/8071093","volume":"2018","author":"P Huang","year":"2018","unstructured":"Huang P, Kaluba B, Jiang XL, Chang S, Tang XF, Mao LF, Zhang ZP, Huang FZ (2018) Liver X receptor inverse agonist SR9243 suppresses nonalcoholic steatohepatitis intrahepatic inflammation and fibrosis. Biomed Res Int 2018:8071093. https:\/\/doi.org\/10.1155\/2018\/8071093","journal-title":"Biomed Res Int"},{"key":"1352_CR55","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00395-009-0071-x","volume":"105","author":"SH Ihm","year":"2010","unstructured":"Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH (2010) Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Res Cardiol 105:399\u2013407. https:\/\/doi.org\/10.1007\/s00395-009-0071-x","journal-title":"Basic Res Cardiol"},{"key":"1352_CR56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","volume":"27","author":"GN Ioannou","year":"2016","unstructured":"Ioannou GN (2016) The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol Metab 27:84\u201395. https:\/\/doi.org\/10.1016\/j.tem.2015.11.008","journal-title":"Trends Endocrinol Metab"},{"key":"1352_CR57","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1194\/jlr.M034876","volume":"54","author":"GN Ioannou","year":"2013","unstructured":"Ioannou GN, Haigh WG, Thorning D, Savard C (2013) Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res 54:1326\u20131334. https:\/\/doi.org\/10.1194\/jlr.M034876","journal-title":"J Lipid Res"},{"key":"1352_CR58","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","volume":"58","author":"GN Ioannou","year":"2017","unstructured":"Ioannou GN, Subramanian S, Chait A, Haigh WG, Yeh MM, Farrell GC, Lee SP, Savard C (2017) Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH. J Lipid Res 58:1067\u20131079. https:\/\/doi.org\/10.1194\/jlr.M072454","journal-title":"J Lipid Res"},{"key":"1352_CR59","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/hep.20170","volume":"39","author":"E Ip","year":"2004","unstructured":"Ip E, Farrell G, Hall P, Robertson G, Leclercq I (2004) Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39:1286\u20131296. https:\/\/doi.org\/10.1002\/hep.20170","journal-title":"Hepatology"},{"key":"1352_CR60","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 75:3313\u20133327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6","journal-title":"Cell Mol Life Sci"},{"key":"1352_CR61","doi-asserted-by":"publisher","first-page":"E1369","DOI":"10.1073\/pnas.1202464109","volume":"109","author":"K Iwaisako","year":"2012","unstructured":"Iwaisako K, Haimerl M, Paik YH, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM, Brenner DA, Schnabl B (2012) Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist. Proc Natl Acad Sci USA 109:E1369\u2013E1376. https:\/\/doi.org\/10.1073\/pnas.1202464109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1352_CR62","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1111\/j.1523-1755.2005.00733.x","volume":"68","author":"T Jiang","year":"2005","unstructured":"Jiang T, Liebman SE, Lucia MS, Li J, Levi M (2005a) Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int 68:2608\u20132620. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00733.x","journal-title":"Kidney Int"},{"key":"1352_CR63","doi-asserted-by":"publisher","first-page":"32317","DOI":"10.1074\/jbc.M500801200","volume":"280","author":"T Jiang","year":"2005","unstructured":"Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, Lucia MS, Li J, Levi M (2005b) Diet-induced obesity in C57BL\/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280:32317\u201332325. https:\/\/doi.org\/10.1074\/jbc.M500801200","journal-title":"J Biol Chem"},{"key":"1352_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/FJC.0b013e31804b4163","volume":"50","author":"BM Jucker","year":"2007","unstructured":"Jucker BM, Doe CP, Schnackenberg CG, Olzinski AR, Maniscalco K, Williams C, Hu TC, Lenhard SC, Costell M, Bernard R, Sarov-Blat L, Steplewski K, Willette RN (2007) PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure. J Cardiovasc Pharmacol 50:25\u201334. https:\/\/doi.org\/10.1097\/FJC.0b013e31804b4163","journal-title":"J Cardiovasc Pharmacol"},{"key":"1352_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1172\/JCI93563","volume":"128","author":"JI Jun","year":"2018","unstructured":"Jun JI, Lau LF (2018) Resolution of organ fibrosis. J Clin Invest 128:97\u2013107. https:\/\/doi.org\/10.1172\/JCI93563","journal-title":"J Clin Invest"},{"key":"1352_CR66","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1096\/fj.201701187R","volume":"32","author":"MY Jung","year":"2018","unstructured":"Jung MY, Kang JH, Hernandez DM, Yin X, Andrianifahanana M, Wang Y, Gonzalez-Guerrico A, Limper AH, Lupu R, Leof EB (2018) Fatty acid synthase is required for profibrotic TGF-beta signaling. FASEB J 32:3803\u20133815. https:\/\/doi.org\/10.1096\/fj.201701187R","journal-title":"FASEB J"},{"key":"1352_CR67","doi-asserted-by":"publisher","first-page":"H305","DOI":"10.1152\/ajpheart.00553.2016","volume":"312","author":"S Kaimoto","year":"2017","unstructured":"Kaimoto S, Hoshino A, Ariyoshi M, Okawa Y, Tateishi S, Ono K, Uchihashi M, Fukai K, Iwai-Kanai E, Matoba S (2017) Activation of PPAR-alpha in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure. Am J Physiol Heart Circ Physiol 312:H305\u2013H313. https:\/\/doi.org\/10.1152\/ajpheart.00553.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1352_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, Park AS, Tao J, Sharma K, Pullman J, Bottinger EP, Goldberg IJ, Susztak K (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21:37\u201346. https:\/\/doi.org\/10.1038\/nm.3762","journal-title":"Nat Med"},{"key":"1352_CR69","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1172\/JCI139519","volume":"130","author":"J Katzen","year":"2020","unstructured":"Katzen J, Beers MF (2020) Contributions of alveolar epithelial cell quality control to pulmonary fibrosis. J Clin Invest 130:5088\u20135099. https:\/\/doi.org\/10.1172\/JCI139519","journal-title":"J Clin Invest"},{"key":"1352_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/labinvest.2008.104","volume":"89","author":"T Kawai","year":"2009","unstructured":"Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N (2009) PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest 89:47\u201358. https:\/\/doi.org\/10.1038\/labinvest.2008.104","journal-title":"Lab Invest"},{"key":"1352_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010024","author":"O Khomich","year":"2019","unstructured":"Khomich O, Ivanov AV, Bartosch B (2019) Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells. https:\/\/doi.org\/10.3390\/cells9010024","journal-title":"Cells"},{"key":"1352_CR72","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cmet.2017.08.011","volume":"26","author":"CW Kim","year":"2017","unstructured":"Kim CW, Addy C, Kusunoki J, Anderson NN, Deja S, Fu X, Burgess SC, Li C, Ruddy M, Chakravarthy M, Previs S, Milstein S, Fitzgerald K, Kelley DE, Horton JD (2017) Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation. Cell Metab 26:576. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.011","journal-title":"Cell Metab"},{"key":"1352_CR73","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4104","volume":"229","author":"F Klingberg","year":"2013","unstructured":"Klingberg F, Hinz B, White ES (2013) The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol 229:298\u2013309. https:\/\/doi.org\/10.1002\/path.4104","journal-title":"J Pathol"},{"key":"1352_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G (2020) Reprogramming of fatty acid metabolism in cancer. Br J Cancer 122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z","journal-title":"Br J Cancer"},{"key":"1352_CR75","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1007\/s00018-016-2268-0","volume":"73","author":"NX Landen","year":"2016","unstructured":"Landen NX, Li D, Stahle M (2016) Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci 73:3861\u20133885. https:\/\/doi.org\/10.1007\/s00018-016-2268-0","journal-title":"Cell Mol Life Sci"},{"key":"1352_CR76","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS Lebleu","year":"2013","unstructured":"Lebleu VS, Taduri G, O\u2019connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047\u20131053. https:\/\/doi.org\/10.1038\/nm.3218","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"1352_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1440-1746.2011.07007.x","volume":"27","author":"YS Lee","year":"2012","unstructured":"Lee YS, Jeong WI (2012) Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol 27(Suppl 2):75\u201379. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.07007.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1352_CR78","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","volume":"42","author":"J Lee","year":"2019","unstructured":"Lee J, Park JS, Roh YS (2019) Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. Arch Pharm Res 42:935\u2013946. https:\/\/doi.org\/10.1007\/s12272-019-01178-1","journal-title":"Arch Pharm Res"},{"key":"1352_CR79","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.22183","volume":"47","author":"Z Li","year":"2008","unstructured":"Li Z, Berk M, Mcintyre TM, Gores GJ, Feldstein AE (2008) The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 47:1495\u20131503. https:\/\/doi.org\/10.1002\/hep.22183","journal-title":"Hepatology"},{"key":"1352_CR80","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1258\/ebm.2009.009218","volume":"235","author":"L Li","year":"2010","unstructured":"Li L, Emmett N, Mann D, Zhao X (2010) Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-kappaB and transforming growth factor-beta1\/Smad3 in diabetic nephropathy. Exp Biol Med (Maywood) 235:383\u2013391. https:\/\/doi.org\/10.1258\/ebm.2009.009218","journal-title":"Exp Biol Med (Maywood)"},{"key":"1352_CR81","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/JCI18945","volume":"112","author":"Y Liu","year":"2003","unstructured":"Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, Mackenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA (2003) Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 112:1678\u20131687. https:\/\/doi.org\/10.1172\/JCI18945","journal-title":"J Clin Invest"},{"key":"1352_CR82","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bcp.2014.07.003","volume":"91","author":"HX Liu","year":"2014","unstructured":"Liu HX, Ly I, Hu Y, Wan YJ (2014) Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration. Biochem Pharmacol 91:256\u2013265. https:\/\/doi.org\/10.1016\/j.bcp.2014.07.003","journal-title":"Biochem Pharmacol"},{"key":"1352_CR83","doi-asserted-by":"publisher","first-page":"H161","DOI":"10.1152\/ajpheart.01065.2004","volume":"291","author":"C Loichot","year":"2006","unstructured":"Loichot C, Jesel L, Tesse A, Tabernero A, Schoonjans K, Roul G, Carpusca I, Auwerx J, Andriantsitohaina R (2006) Deletion of peroxisome proliferator-activated receptor-alpha \ninduces an alteration of cardiac functions. Am J Physiol Heart Circ Physiol 291:H161\u2013H166. https:\/\/doi.org\/10.1152\/ajpheart.01065.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1352_CR84","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","volume":"155","author":"R Loomba","year":"2018","unstructured":"Loomba R, Kayali Z, Noureddin M, Ruane P, Lawitz EJ, Bennett M, Wang L, Harting E, Tarrant JM, Mccolgan BJ, Chung C, Ray AS, Subramanian GM, Myers RP, Middleton MS, Lai M, Charlton M, Harrison SA (2018) GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease. Gastroenterology 155:1463-1473.e6. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.027","journal-title":"Gastroenterology"},{"key":"1352_CR85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207\u2013258. https:\/\/doi.org\/10.1152\/physrev.00015.2009","journal-title":"Physiol Rev"},{"key":"1352_CR86","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ (2018) Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci 14:1645\u20131657. https:\/\/doi.org\/10.7150\/ijbs.28103","journal-title":"Int J Biol Sci"},{"key":"1352_CR87","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2014.287","volume":"87","author":"M Mack","year":"2015","unstructured":"Mack M, Yanagita M (2015) Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int 87:297\u2013307. https:\/\/doi.org\/10.1038\/ki.2014.287","journal-title":"Kidney Int"},{"key":"1352_CR88","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.1073\/pnas.0603115103","volume":"103","author":"J Mao","year":"2006","unstructured":"Mao J, Demayo FJ, Li H, Abu-Elheiga L, Gu Z, Shaikenov TE, Kordari P, Chirala SS, Heird WC, Wakil SJ (2006) Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA 103:8552\u20138557. https:\/\/doi.org\/10.1073\/pnas.0603115103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1352_CR89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140695","author":"V Miguel","year":"2021","unstructured":"Miguel V, Tituana J, Herrero JI, Herrero L, Serra D, Cuevas P, Barbas C, Puyol DR, Marquez-Exposito L, Ruiz-Ortega M, Castillo C, Sheng X, Susztak K, Ruiz-Canela M, Salas-Salvado J, Gonzalez MAM, Ortega S, Ramos R, Lamas S (2021) Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI140695","journal-title":"J Clin Invest"},{"key":"1352_CR90","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","volume":"65","author":"A Montagner","year":"2016","unstructured":"Montagner A, Polizzi A, Fouche E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Regnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, Loiseau N, Postic C, Langin D, Wahli W, Guillou H (2016) Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65:1202\u20131214. https:\/\/doi.org\/10.1136\/gutjnl-2015-310798","journal-title":"Gut"},{"key":"1352_CR91","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1172\/JCI35847","volume":"118","author":"RL Montgomery","year":"2008","unstructured":"Montgomery RL, Potthoff MJ, Haberland M, Qi X, Matsuzaki S, Humphries KM, Richardson JA, Bassel-Duby R, Olson EN (2008) Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J Clin Invest 118:3588\u20133597. https:\/\/doi.org\/10.1172\/JCI35847","journal-title":"J Clin Invest"},{"key":"1352_CR92","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/j.gastro.2011.09.051","volume":"142","author":"T Moustafa","year":"2012","unstructured":"Moustafa T, Fickert P, Magnes C, Guelly C, Thueringer A, Frank S, Kratky D, Sattler W, Reicher H, Sinner F, Gumhold J, Silbert D, Fauler G, Hofler G, Lass A, Zechner R, Trauner M (2012) Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology 142:140-151.e12. https:\/\/doi.org\/10.1053\/j.gastro.2011.09.051","journal-title":"Gastroenterology"},{"key":"1352_CR93","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66:1037\u20131046. https:\/\/doi.org\/10.1016\/j.jhep.2017.01.022","journal-title":"J Hepatol"},{"key":"1352_CR94","doi-asserted-by":"publisher","first-page":"F614","DOI":"10.1152\/ajprenal.00140.2016","volume":"311","author":"M Mustafa","year":"2016","unstructured":"Mustafa M, Wang TN, Chen X, Gao B, Krepinsky JC (2016) SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction. Am J Physiol Renal Physiol 311:F614\u2013F625. https:\/\/doi.org\/10.1152\/ajprenal.00140.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"1352_CR95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"RH Nelson","year":"2013","unstructured":"Nelson RH (2013) Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care 40:195\u2013211. https:\/\/doi.org\/10.1016\/j.pop.2012.11.003","journal-title":"Prim Care"},{"key":"1352_CR96","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1681\/ASN.2008010009","volume":"20","author":"DM Okamura","year":"2009","unstructured":"Okamura DM, Pennathur S, Pasichnyk K, Lopez-Guisa JM, Collins S, Febbraio M, Heinecke J, Eddy AA (2009) CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol 20:495\u2013505. https:\/\/doi.org\/10.1681\/ASN.2008010009","journal-title":"J Am Soc Nephrol"},{"key":"1352_CR97","doi-asserted-by":"publisher","first-page":"E2048","DOI":"10.1073\/pnas.1415111112","volume":"112","author":"G Oruqaj","year":"2015","unstructured":"Oruqaj G, Karnati S, Vijayan V, Kotarkonda LK, Boateng E, Zhang W, Ruppert C, Gunther A, Shi W, Baumgart-Vogt E (2015) Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-beta signaling. Proc Natl Acad Sci USA 112:E2048\u2013E2057. https:\/\/doi.org\/10.1073\/pnas.1415111112","journal-title":"Proc Natl Acad Sci USA"},{"key":"1352_CR98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3238\/arztebl.2016.0261","volume":"113","author":"KG Parhofer","year":"2016","unstructured":"Parhofer KG (2016) The treatment of disorders of lipid metabolism. Dtsch Arztebl Int 113:261\u2013268. https:\/\/doi.org\/10.3238\/arztebl.2016.0261","journal-title":"Dtsch Arztebl Int"},{"key":"1352_CR99","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/hep.27297","volume":"60","author":"M Pawlak","year":"2014","unstructured":"Pawlak M, Bauge E, Bourguet W, De Bosscher K, Lalloyer F, Tailleux A, Lebherz C, Lefebvre P, Staels B (2014) The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. Hepatology 60:1593\u20131606. https:\/\/doi.org\/10.1002\/hep.27297","journal-title":"Hepatology"},{"key":"1352_CR100","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B (2015) Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol 62:720\u2013733. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.039","journal-title":"J Hepatol"},{"key":"1352_CR101","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.1074\/jbc.M111.303669","volume":"287","author":"L Plantier","year":"2012","unstructured":"Plantier L, Besnard V, Xu Y, Ikegami M, Wert SE, Hunt AN, Postle AD, Whitsett JA (2012) Activation of sterol-response element-binding proteins (SREBP) in alveolar type II cells enhances lipogenesis causing pulmonary lipotoxicity. J Biol Chem 287:10099\u201310114. https:\/\/doi.org\/10.1074\/jbc.M111.303669","journal-title":"J Biol Chem"},{"issue":"8","key":"1352_CR102","first-page":"927","volume":"5","author":"M Rafieian-Kopaei","year":"2014","unstructured":"Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H (2014) Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med 5(8):927\u2013946","journal-title":"Int J Prev Med"},{"key":"1352_CR103","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","volume":"24","author":"S Rangarajan","year":"2018","unstructured":"Rangarajan S, Bone NB, Zmijewska AA, Jiang S, Park DW, Bernard K, Locy ML, Ravi S, Deshane J, Mannon RB, Abraham E, Darley-Usmar V, Thannickal VJ, Zmijewski JW (2018) Metformin reverses established lung fibrosis in a bleomycin model. Nat Med 24:1121\u20131127. https:\/\/doi.org\/10.1038\/s41591-018-0087-6","journal-title":"Nat Med"},{"issue":"e5","key":"1352_CR104","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","volume":"150","author":"V Ratziu","year":"2016","unstructured":"Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A, Group G-IS (2016) Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology 150(e5):1147\u20131159. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.038","journal-title":"Gastroenterology"},{"key":"1352_CR105","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1152\/physrev.00067.2017","volume":"99","author":"M Rodrigues","year":"2019","unstructured":"Rodrigues M, Kosaric N, Bonham CA, Gurtner GC (2019) Wound healing: a cellular perspective. Physiol Rev 99:665\u2013706. https:\/\/doi.org\/10.1152\/physrev.00067.2017","journal-title":"Physiol Rev"},{"key":"1352_CR106","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1165\/rcmb.2017-0340OC","volume":"59","author":"F Romero","year":"2018","unstructured":"Romero F, Hong X, Shah D, Kallen CB, Rosas I, Guo Z, Schriner D, Barta J, Shaghaghi H, Hoek JB, Mesaros C, Choi AM, Snyder NW, Summer R (2018) Lipid synthesis is required to resolve endoplasmic reticulum stress and limit fibrotic responses in the lung. Am J Respir Cell Mol Biol 59:225\u2013236. https:\/\/doi.org\/10.1165\/rcmb.2017-0340OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1352_CR107","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1046\/j.1523-1755.2002.00277.x","volume":"61","author":"RE Routh","year":"2002","unstructured":"Routh RE, Johnson JH, Mccarthy KJ (2002) Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro. Kidney Int 61:1365\u20131376. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00277.x","journal-title":"Kidney Int"},{"key":"1352_CR108","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui L (2014) Energy metabolism in the liver. Compr Physiol 4:177\u2013197. https:\/\/doi.org\/10.1002\/cphy.c130024","journal-title":"Compr Physiol"},{"key":"1352_CR109","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","volume":"118","author":"PC Schulze","year":"2016","unstructured":"Schulze PC, Drosatos K, Goldberg IJ (2016) Lipid use and misuse by the heart. Circ Res 118:1736\u20131751. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306842","journal-title":"Circ Res"},{"key":"1352_CR110","doi-asserted-by":"publisher","first-page":"a016311","DOI":"10.1101\/cshperspect.a016311","volume":"7","author":"CN Serhan","year":"2014","unstructured":"Serhan CN, Chiang N, Dalli J, Levy BD (2014) Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol 7:a016311. https:\/\/doi.org\/10.1101\/cshperspect.a016311","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1352_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122163","author":"S Shichino","year":"2019","unstructured":"Shichino S, Ueha S, Hashimoto S, Otsuji M, Abe J, Tsukui T, Deshimaru S, Nakajima T, Kosugi-Kanaya M, Shand FH, Inagaki Y, Shimano H, Matsushima K (2019) Transcriptome network analysis identifies protective role of the LXR\/SREBP-1c axis in murine pulmonary fibrosis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.122163","journal-title":"JCI Insight"},{"key":"1352_CR112","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5114\/ceh.2021.106864","volume":"7","author":"S Shinozaki","year":"2021","unstructured":"Shinozaki S, Tahara T, Lefor AK, Ogura M (2021) Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study. Clin Exp Hepatol 7:172\u2013177. https:\/\/doi.org\/10.5114\/ceh.2021.106864","journal-title":"Clin Exp Hepatol"},{"key":"1352_CR113","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/joim.12728","volume":"284","author":"AC Sletten","year":"2018","unstructured":"Sletten AC, Peterson LR, Schaffer JE (2018) Manifestations and mechanisms of myocardial lipotoxicity in obesity. J Intern Med 284:478\u2013491. https:\/\/doi.org\/10.1111\/joim.12728","journal-title":"J Intern Med"},{"key":"1352_CR114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/cvr\/cvn001","volume":"78","author":"PJ Smeets","year":"2008","unstructured":"Smeets PJ, Teunissen BE, Willemsen PH, Van Nieuwenhoven FA, Brouns AE, Janssen BJ, Cleutjens JP, Staels B, Van Der Vusse GJ, Van Bilsen M (2008) Cardiac hypertrophy is enhanced in PPAR alpha-\/- mice in response to chronic pressure overload. Cardiovasc Res 78:79\u201389. https:\/\/doi.org\/10.1093\/cvr\/cvn001","journal-title":"Cardiovasc Res"},{"key":"1352_CR115","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molmet.2015.03.004","volume":"4","author":"G Solinas","year":"2015","unstructured":"Solinas G, Boren J, Dulloo AG (2015) De novo lipogenesis in metabolic homeostasis: more friend than foe? Mol Metab 4:367\u2013377. https:\/\/doi.org\/10.1016\/j.molmet.2015.03.004","journal-title":"Mol Metab"},{"key":"1352_CR116","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1172\/JCI30335","volume":"117","author":"NH Son","year":"2007","unstructured":"Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, Homma S, Szabolcs MJ, Huang LS, Goldberg IJ (2007) Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest 117:2791\u20132801. https:\/\/doi.org\/10.1172\/JCI30335","journal-title":"J Clin Invest"},{"key":"1352_CR117","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","volume":"89","author":"AC Souza","year":"2016","unstructured":"Souza AC, Bocharov AV, Baranova IN, Vishnyakova TG, Huang YG, Wilkins KJ, Hu X, Street JM, Alvarez-Prats A, Mullick AE, Patterson AP, Remaley AT, Eggerman TL, Yuen PS, Star RA (2016) Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int 89:809\u2013822. https:\/\/doi.org\/10.1016\/j.kint.2015.12.043","journal-title":"Kidney Int"},{"key":"1352_CR118","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/hep.26461","volume":"58","author":"B Staels","year":"2013","unstructured":"Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, Baron M, Lucas A, Tailleux A, Hum DW, Ratziu V, Cariou B, Hanf R (2013) Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Hepatology 58:1941\u20131952. https:\/\/doi.org\/10.1002\/hep.26461","journal-title":"Hepatology"},{"key":"1352_CR119","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1165\/rcmb.2019-0098ED","volume":"61","author":"R Summer","year":"2019","unstructured":"Summer R, Mora AL (2019) Lipid metabolism: a new player in the conundrum of lung fibrosis. Am J Respir Cell Mol Biol 61:669\u2013670. https:\/\/doi.org\/10.1165\/rcmb.2019-0098ED","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1352_CR120","doi-asserted-by":"publisher","first-page":"33301","DOI":"10.1074\/jbc.M111.277707","volume":"286","author":"Z Sun","year":"2011","unstructured":"Sun Z, Singh N, Mullican SE, Everett LJ, Li L, Yuan L, Liu X, Epstein JA, Lazar MA (2011) Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J Biol Chem 286:33301\u201333309. https:\/\/doi.org\/10.1074\/jbc.M111.277707","journal-title":"J Biol Chem"},{"key":"1352_CR121","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/ncomms3563","volume":"4","author":"H Sunaga","year":"2013","unstructured":"Sunaga H, Matsui H, Ueno M, Maeno T, Iso T, Syamsunarno MR, Anjo S, Matsuzaka T, Shimano H, Yokoyama T, Kurabayashi M (2013) Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice. Nat Commun 4:2563. https:\/\/doi.org\/10.1038\/ncomms3563","journal-title":"Nat Commun"},{"key":"1352_CR122","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MOL.0000000000000443","volume":"28","author":"H Sunshine","year":"2017","unstructured":"Sunshine H, Iruela-Arispe ML (2017) Membrane lipids and cell signaling. Curr Opin Lipidol 28:408\u2013413. https:\/\/doi.org\/10.1097\/MOL.0000000000000443","journal-title":"Curr Opin Lipidol"},{"key":"1352_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124257","author":"V Suryadevara","year":"2020","unstructured":"Suryadevara V, Ramchandran R, Kamp DW, Natarajan V (2020) Lipid mediators regulate pulmonary fibrosis: potential mechanisms and signaling pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124257","journal-title":"Int J Mol Sci"},{"key":"1352_CR124","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12272-019-01192-3","volume":"43","author":"K Taguchi","year":"2020","unstructured":"Taguchi K, Kensler TW (2020) Nrf2 in liver toxicology. Arch Pharm Res 43:337\u2013349. https:\/\/doi.org\/10.1007\/s12272-019-01192-3","journal-title":"Arch Pharm Res"},{"key":"1352_CR125","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","volume":"142","author":"T Teratani","year":"2012","unstructured":"Teratani T, Tomita K, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Tominaga S, Hiroi S, Irie R, Okada Y, Kurihara C, Ebinuma H, Saito H, Hokari R, Sugiyama K, Kanai T, Miura S, Hibi T (2012) A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. Gastroenterology 142:152-164.e10. https:\/\/doi.org\/10.1053\/j.gastro.2011.09.049","journal-title":"Gastroenterology"},{"key":"1352_CR126","doi-asserted-by":"publisher","first-page":"e34945","DOI":"10.1371\/journal.pone.0034945","volume":"7","author":"N Testerink","year":"2012","unstructured":"Testerink N, Ajat M, Houweling M, Brouwers JF, Pully VV, Van Manen HJ, Otto C, Helms JB, Vaandrager AB (2012) Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of hepatic stellate cells during activation. PLoS ONE 7:e34945. https:\/\/doi.org\/10.1371\/journal.pone.0034945","journal-title":"PLoS ONE"},{"key":"1352_CR127","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41467-021-21301-5","volume":"12","author":"Z Tian","year":"2021","unstructured":"Tian Z, Liang M (2021) Renal metabolism and hypertension. Nat Commun 12:963. https:\/\/doi.org\/10.1038\/s41467-021-21301-5","journal-title":"Nat Commun"},{"key":"1352_CR128","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1755-1536-5-11","volume":"5","author":"NW Todd","year":"2012","unstructured":"Todd NW, Luzina IG, Atamas SP (2012) Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair 5:11. https:\/\/doi.org\/10.1186\/1755-1536-5-11","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1352_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2014.03.018","volume":"61","author":"K Tomita","year":"2014","unstructured":"Tomita K, Teratani T, Suzuki T, Shimizu M, Sato H, Narimatsu K, Usui S, Furuhashi H, Kimura A, Nishiyama K, Maejima T, Okada Y, Kurihara C, Shimamura K, Ebinuma H, Saito H, Yokoyama H, Watanabe C, Komoto S, Nagao S, Sugiyama K, Aosasa S, Hatsuse K, Yamamoto J, Hibi T, Miura S, Hokari R, Kanai T (2014) Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells. J Hepatol 61:98\u2013106. https:\/\/doi.org\/10.1016\/j.jhep.2014.03.018","journal-title":"J Hepatol"},{"key":"1352_CR130","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC (2016) Cardiac fibrosis: the fibroblast awakens. Circ Res 118:1021\u20131040. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306565","journal-title":"Circ Res"},{"key":"1352_CR131","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14:397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1352_CR132","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1194\/jlr.M070631","volume":"58","author":"JN Van Der Veen","year":"2017","unstructured":"Van Der Veen JN, Lingrell S, Gao X, Takawale A, Kassiri Z, Vance DE, Jacobs RL (2017) Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase. J Lipid Res 58:656\u2013667. https:\/\/doi.org\/10.1194\/jlr.M070631","journal-title":"J Lipid Res"},{"key":"1352_CR133","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","volume":"1812","author":"T Varga","year":"2011","unstructured":"Varga T, Czimmerer Z, Nagy L (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 1812:1007\u20131022. https:\/\/doi.org\/10.1016\/j.bbadis.2011.02.014","journal-title":"Biochim Biophys Acta"},{"key":"1352_CR134","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1124\/jpet.104.080259","volume":"313","author":"RK Vikramadithyan","year":"2005","unstructured":"Vikramadithyan RK, Hirata K, Yagyu H, Hu Y, Augustus A, Homma S, Goldberg IJ (2005) Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy. J Pharmacol Exp Ther 313:586\u2013593. https:\/\/doi.org\/10.1124\/jpet.104.080259","journal-title":"J Pharmacol Exp Ther"},{"key":"1352_CR135","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola A, Munari F, Sanchez-Rodriguez R, Scolaro T, Castegna A (2019) The metabolic signature of macrophage responses. Front Immunol 10:1462. https:\/\/doi.org\/10.3389\/fimmu.2019.01462","journal-title":"Front Immunol"},{"key":"1352_CR136","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","volume":"50","author":"SJ Wakil","year":"2009","unstructured":"Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50:S138\u2013S143. https:\/\/doi.org\/10.1194\/jlr.R800079-JLR200","journal-title":"J Lipid Res"},{"key":"1352_CR137","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","volume":"81","author":"TC Walther","year":"2012","unstructured":"Walther TC, Farese RV Jr (2012) Lipid droplets and cellular lipid metabolism. Annu Rev Biochem 81:687\u2013714. https:\/\/doi.org\/10.1146\/annurev-biochem-061009-102430","journal-title":"Annu Rev Biochem"},{"key":"1352_CR138","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbalip.2010.01.001","volume":"1801","author":"RJ Wanders","year":"2010","unstructured":"Wanders RJ, Ferdinandusse S, Brites P, Kemp S (2010) Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta 1801:272\u2013280. https:\/\/doi.org\/10.1016\/j.bbalip.2010.01.001","journal-title":"Biochim Biophys Acta"},{"key":"1352_CR139","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCRESAHA.109.206185","volume":"106","author":"P Wang","year":"2010","unstructured":"Wang P, Liu J, Li Y, Wu S, Luo J, Yang H, Subbiah R, Chatham J, Zhelyabovska O, Yang Q (2010) Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart. Circ Res 106:911\u2013919. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.206185","journal-title":"Circ Res"},{"key":"1352_CR140","doi-asserted-by":"publisher","first-page":"8936856","DOI":"10.1155\/2019\/8936856","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pang L, Zhang Y, Lin J, Zhou H (2019) Fenofibrate improved interstitial fibrosis of renal allograft through inhibited epithelial-mesenchymal transition induced by oxidative stress. Oxid Med Cell Longev 2019:8936856. https:\/\/doi.org\/10.1155\/2019\/8936856","journal-title":"Oxid Med Cell Longev"},{"key":"1352_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062061","author":"Y Wang","year":"2020","unstructured":"Wang Y, Nakajima T, Gonzalez FJ, Tanaka N (2020) PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21062061","journal-title":"Int J Mol Sci"},{"key":"1352_CR142","doi-asserted-by":"publisher","first-page":"22293","DOI":"10.1074\/jbc.M000248200","volume":"275","author":"K Watanabe","year":"2000","unstructured":"Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T (2000) Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem 275:22293\u201322299. https:\/\/doi.org\/10.1074\/jbc.M000248200","journal-title":"J Biol Chem"},{"key":"1352_CR143","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000486220","volume":"45","author":"WY Wei","year":"2018","unstructured":"Wei WY, Zhang N, Li LL, Ma ZG, Xu M, Yuan YP, Deng W, Tang QZ (2018) Pioglitazone alleviates cardiac fibrosis and inhibits endothelial to mesenchymal transition induced by pressure overload. Cell Physiol Biochem 45:26\u201336. https:\/\/doi.org\/10.1159\/000486220","journal-title":"Cell Physiol Biochem"},{"key":"1352_CR144","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","volume":"65","author":"R Weiskirchen","year":"2019","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F (2019) Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med 65:2\u201315. https:\/\/doi.org\/10.1016\/j.mam.2018.06.003","journal-title":"Mol Aspects Med"},{"key":"1352_CR145","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","volume":"12","author":"RG Wells","year":"2008","unstructured":"Wells RG (2008) Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 12:759\u2013768. https:\/\/doi.org\/10.1016\/j.cld.2008.07.008","journal-title":"Clin Liver Dis"},{"key":"1352_CR146","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1056\/NEJMc2031135","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M, Cottin V (2020) Spectrum of fibrotic lung diseases. Reply. N Engl J Med 383:2485\u20132486. https:\/\/doi.org\/10.1056\/NEJMc2031135","journal-title":"N Engl J Med"},{"key":"1352_CR147","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/cr.2009.73","volume":"19","author":"H Wobser","year":"2009","unstructured":"Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Buttner R, Scholmerich J, Hellerbrand C (2009) Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 19:996\u20131005. https:\/\/doi.org\/10.1038\/cr.2009.73","journal-title":"Cell Res"},{"key":"1352_CR148","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.taap.2012.05.010","volume":"262","author":"KC Wu","year":"2012","unstructured":"Wu KC, Liu J, Klaassen CD (2012) Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicol Appl Pharmacol 262:321\u2013329. https:\/\/doi.org\/10.1016\/j.taap.2012.05.010","journal-title":"Toxicol Appl Pharmacol"},{"key":"1352_CR149","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2019.11.027","volume":"180","author":"H Wu","year":"2020","unstructured":"Wu H, Yu Y, Huang H, Hu Y, Fu S, Wang Z, Shi M, Zhao X, Yuan J, Li J, Yang X, Bin E, Wei D, Zhang H, Zhang J, Yang C, Cai T, Dai H, Chen J, Tang N (2020) Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells. Cell 180:107-121.e17. https:\/\/doi.org\/10.1016\/j.cell.2019.11.027","journal-title":"Cell"},{"key":"1352_CR150","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","volume":"192","author":"N Xie","year":"2015","unstructured":"Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu RM, Bernard K, Thannickal VJ, Liu G (2015) Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med 192:1462\u20131474. https:\/\/doi.org\/10.1164\/rccm.201504-0780OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1352_CR151","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0033-1358523","volume":"33","author":"X Xu","year":"2013","unstructured":"Xu X, So JS, Park JG, Lee AH (2013) Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis 33:301\u2013311. https:\/\/doi.org\/10.1055\/s-0033-1358523","journal-title":"Semin Liver Dis"},{"key":"1352_CR152","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1172\/JCI16751","volume":"111","author":"H Yagyu","year":"2003","unstructured":"Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, Goldberg IJ (2003) Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 111:419\u2013426. https:\/\/doi.org\/10.1172\/JCI16751","journal-title":"J Clin Invest"},{"key":"1352_CR153","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","volume":"100","author":"J Yang","year":"2007","unstructured":"Yang J, Sambandam N, Han X, Gross RW, Courtois M, Kovacs A, Febbraio M, Finck BN, Kelly DP (2007) CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 100:1208\u20131217. https:\/\/doi.org\/10.1161\/01.RES.0000264104.25265.b6","journal-title":"Circ Res"},{"key":"1352_CR154","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00011-010-0226-0","volume":"59","author":"L Yang","year":"2010","unstructured":"Yang L, Stimpson SA, Chen L, Wallace Harrington W, Rockey DC (2010) Effectiveness of the PPARgamma agonist, GW570, in liver fibrosis. Inflamm Res 59:1061\u20131071. https:\/\/doi.org\/10.1007\/s00011-010-0226-0","journal-title":"Inflamm Res"},{"key":"1352_CR155","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.26698","volume":"59","author":"L Yang","year":"2014","unstructured":"Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R, Seki E (2014) Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology 59:483\u2013495. https:\/\/doi.org\/10.1002\/hep.26698","journal-title":"Hepatology"},{"key":"1352_CR156","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jssc.201500899","volume":"39","author":"L Yang","year":"2016","unstructured":"Yang L, Li M, Shan Y, Shen S, Bai Y, Liu H (2016) Recent advances in lipidomics for disease research. J Sep Sci 39:38\u201350. https:\/\/doi.org\/10.1002\/jssc.201500899","journal-title":"J Sep Sci"},{"key":"1352_CR157","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang X, Okamura DM, Lu X, Chen Y, Moorhead J, Varghese Z, Ruan XZ (2017) CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat Rev Nephrol 13:769\u2013781. https:\/\/doi.org\/10.1038\/nrneph.2017.126","journal-title":"Nat Rev Nephrol"},{"key":"1352_CR158","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nm.4447","volume":"24","author":"G Yu","year":"2018","unstructured":"Yu G, Tzouvelekis A, Wang R, Herazo-Maya JD, Ibarra GH, Srivastava A, De Castro JPW, Deiuliis G, Ahangari F, Woolard T, Aurelien N, Arrojo EDR, Gan Y, Graham M, Liu X, Homer RJ, Scanlan TS, Mannam P, Lee PJ, Herzog EL, Bianco AC, Kaminski N (2018) Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med 24:39\u201349. https:\/\/doi.org\/10.1038\/nm.4447","journal-title":"Nat Med"},{"key":"1352_CR159","doi-asserted-by":"publisher","first-page":"112689","DOI":"10.1016\/j.yexcr.2021.112689","volume":"405","author":"H Yu","year":"2021","unstructured":"Yu H, Jiang X, Dong F, Zhang F, Ji X, Xue M, Yang F, Chen J, Hu X, Bao Z (2021) Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway. Exp Cell Res 405:112689. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112689","journal-title":"Exp Cell Res"},{"key":"1352_CR160","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2019.02.037","volume":"851","author":"H Zhang","year":"2019","unstructured":"Zhang H, You L, Zhao M (2019) Rosiglitazone attenuates paraquat-induced lung fibrosis in rats in a PPAR gamma-dependent manner. Eur J Pharmacol 851:133\u2013143. https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.037","journal-title":"Eur J Pharmacol"},{"key":"1352_CR161","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/j.xcrm.2020.100056","volume":"1","author":"J Zhang","year":"2020","unstructured":"Zhang J, Muise ES, Han S, Kutchukian PS, Costet P, Zhu Y, Kan Y, Zhou H, Shah V, Huang Y, Saigal A, Akiyama TE, Shen XL, Cai TQ, Shah K, Carballo-Jane E, Zycband E, Yi L, Tian Y, Chen Y, Imbriglio J, Smith E, Devito K, Conway J, Ma LJ, Hoek M, Sebhat IK, Peier AM, Talukdar S, Mclaren DG, Previs SF, Jensen KK, Pinto S (2020) Molecular profiling reveals a common metabolic signature of tissue fibrosis. Cell Rep Med 1:100056. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100056","journal-title":"Cell Rep Med"},{"key":"1352_CR162","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","volume":"19","author":"X Zhao","year":"2020","unstructured":"Zhao X, Kwan JYY, Yip K, Liu PP, Liu FF (2020) Targeting metabolic dysregulation for fibrosis therapy. Nat Rev Drug Discov 19:57\u201375. https:\/\/doi.org\/10.1038\/s41573-019-0040-5","journal-title":"Nat Rev Drug Discov"},{"key":"1352_CR163","doi-asserted-by":"publisher","first-page":"173300","DOI":"10.1016\/j.ejphar.2020.173300","volume":"882","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Deng L, Hu L, Ren Q, Cai Z, Wang B, Li Z, Zhang L (2020) Hepatoprotective effects of ZLY16, a dual peroxisome proliferator-activated receptor alpha\/delta agonist, in rodent model of nonalcoholic steatohepatitis. Eur J Pharmacol 882:173300. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173300","journal-title":"Eur J Pharmacol"},{"key":"1352_CR164","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamacardio.2016.4320","volume":"2","author":"B Ziaeian","year":"2017","unstructured":"Ziaeian B, Fonarow GC (2017) Statins and the prevention of heart disease. JAMA Cardiol 2:464. https:\/\/doi.org\/10.1001\/jamacardio.2016.4320","journal-title":"JAMA Cardiol"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-021-01352-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-021-01352-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-021-01352-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T05:09:12Z","timestamp":1637212152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-021-01352-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":164,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1007\/s12272-021-01352-4","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}